Literature DB >> 3532744

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

W B Kannel, J D Neaton, D Wentworth, H E Thomas, J Stamler, S B Hulley, M O Kjelsberg.   

Abstract

The influence of risk factors on CHD and all-cause mortality rates in 35- to 57-year-old men is examined by means of data on 325,348 white men who were screened for the MRFIT. This large data set permits an unusually detailed analysis of factors associated with the 6968 deaths, including 2426 ascribed to CHD, that were detected in the Social Security Administration data set during 6 years of follow-up. Simple cross classification of the data confirms the independent effect of serum cholesterol concentration, diastolic blood pressure, and cigarette smoking as risk factors for CHD and all-cause mortality rates. A distinct escalation of risk is noted for combinations of these risk factors. The strength of the association of each of the risk factors with CHD and all-cause mortality rates diminished with increasing age, although the number of excess deaths attributable to the risk factors increased because of the higher death rates in older men. Comparison of these findings with those observed in the five populations studied in the Pooling Project revealed an overall similarity in the risk relationships. It is estimated that elimination of these risk factors has the potential for reducing the CHD mortality rate by two thirds in 35- to 45-year old men, and by one half in 46- to 57-year-old men.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532744     DOI: 10.1016/0002-8703(86)90481-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  74 in total

1.  Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study.

Authors:  A Menotti; H Blackburn; D Kromhout; A Nissinen; H Adachi; M Lanti
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

3.  Value of the Dundee coronary risk-disk: a defence.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1992-07-25

Review 4.  Communicating risks at the population level: application of population impact numbers.

Authors:  Richard F Heller; Iain Buchan; Richard Edwards; Georgios Lyratzopoulos; Patrick McElduff; Selwyn St Leger
Journal:  BMJ       Date:  2003-11-15

Review 5.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  All cause mortality and its determinants in middle aged men in Finland, The Netherlands, and Italy in a 25 year follow up.

Authors:  A Menotti; A Keys; D Kromhout; A Nissinen; H Blackburn; F Fidanza; S Giampaoli; M Karvonen; J Pekkanen; S Punsar
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

Review 7.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

8.  Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: a cross-cultural comparison through Europe.

Authors:  Alessandro Menotti; Mariapaola Lanti; Daan Kromhout; Anthony Kafatos; Srecko Nedeljkovic; Aulikki Nissinen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

9.  The effect of modifiable risk factors on geographic mortality differentials: a modelling study.

Authors:  Christopher E Stevenson; Haider Mannan; Anna Peeters; Helen Walls; Dianna J Magliano; Jonathan E Shaw; John J McNeil
Journal:  BMC Public Health       Date:  2012-01-25       Impact factor: 3.295

Review 10.  Cardiovascular risk factors in perspective.

Authors:  S G Carruthers
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.